Tower Research Capital (TRC)’s BioRestorative Therapies BRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.13K | Sell |
1,278
-1,919
| -60% | -$3.2K | ﹤0.01% | 4693 |
|
2025
Q1 | $5.69K | Buy |
3,197
+1,620
| +103% | +$2.88K | ﹤0.01% | 4095 |
|
2024
Q4 | $2.26K | Sell |
1,577
-574
| -27% | -$821 | ﹤0.01% | 4880 |
|
2024
Q3 | $3.74K | Sell |
2,151
-2,644
| -55% | -$4.6K | ﹤0.01% | 4779 |
|
2024
Q2 | $9.73K | Buy |
4,795
+2,134
| +80% | +$4.33K | ﹤0.01% | 4213 |
|
2024
Q1 | $3.67K | Buy |
2,661
+1,817
| +215% | +$2.51K | ﹤0.01% | 4821 |
|
2023
Q4 | $1.47K | Buy |
+844
| New | +$1.47K | ﹤0.01% | 5376 |
|
2023
Q3 | – | Sell |
-740
| Closed | -$3.26K | – | 5958 |
|
2023
Q2 | $3.26K | Sell |
740
-472
| -39% | -$2.08K | ﹤0.01% | 5068 |
|
2023
Q1 | $4K | Sell |
1,212
-2,969
| -71% | -$9.8K | ﹤0.01% | 5049 |
|
2022
Q4 | $11K | Buy |
4,181
+1,927
| +85% | +$5.07K | ﹤0.01% | 3791 |
|
2022
Q3 | $7K | Sell |
2,254
-111
| -5% | -$345 | ﹤0.01% | 4870 |
|
2022
Q2 | $7K | Buy |
2,365
+1,435
| +154% | +$4.25K | ﹤0.01% | 4765 |
|
2022
Q1 | $5K | Buy |
+930
| New | +$5K | ﹤0.01% | 5022 |
|